Others suspect true microbiome shifts
Jastreboff, who wasnt involved in the study, said the trial could be a turning point for treating cardiovascular disease
Weight Loss Treatments In Dallas Getting Started With Aspire Rejuvenation Is Easy
These may include a GLP-1 agonist plus supporting ingredients like amino acids, B vitamins, and metabolic cofactors designed to work synergistically
doi.org/10.1038/newbio243085a0 Sikiri, P., et al
Now, its a small subgroup and clearly that needs some further exploration. Overall, McMurray called the trial a very important and encouraging first step in understanding the use of GLP-1 receptor agonists in patients with heart failure, adding, We obviously need bigger, longer-term outcome trials. Vaduganathan also highlighted the need for additional research into the impact of GLP-1 receptor agonists in heart failure, noting that the STEP-HFpEF DM trial, which includes patients with type 2 diabetes, will provide additional information